| Document |
Document Title |
|
WO/2016/145997A1 |
Disclosed are a pharmaceutically active sugar molecule and a synthesis method thereof. The sugar molecule has a structure as shown by formula (I) or (II) and can be used for synthesizing a sulfonated sugar molecule, so that it can be fur...
|
|
WO/2016/145478A1 |
The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of kidney and/or liver disease.
|
|
WO/2016/146941A1 |
The present invention relates to a new method for producing D-galacturonic derivatives and compositions having the formula (I) directly from pectins or pectin depolymerisation products, and to their use as surface active agents.
|
|
WO/2016/144175A1 |
The present invention relates generally to the production of steviol glycosides. Provided is a method for enzymatically providing a modified steviol glycoside, comprising incubating a steviol glycoside substrate in the presence of sucros...
|
|
WO/2016/143939A1 |
The present invention relates to a production method for a complex of a steviol glycoside and a sparingly soluble material having improved solubility, and to a complex of a steviol glycoside and a sparingly soluble material having improv...
|
|
WO/2016/142529A1 |
The present invention relates to a galactolipid having the following formula (I): (I) or compositions containing same, for use thereof in healing, in repair, reinforcement and re-equilibration of the skin barrier, in skin hydration and i...
|
|
WO/2016/145164A1 |
Provided herein are compounds, compositions, and methods having application in the field of enhanced oil recovery (EOR). In particular, the short hydrophobe anionic surfactants as well as aqueous compositions comprising these surfactants...
|
|
WO/2016/145192A1 |
Compositions and methods of utilizing the same are provided for treating bacterial infections. The compositions comprise acidified nitrite in combination with an iron chelator and an antibiotic. The compositions of the present invention ...
|
|
WO/2016/140355A1 |
The present invention provides a porous polymer compound having a three dimensional skeleton and pores and/or voids that are partitioned and formed by the three dimensional skeleton, said porous polymer compound being characterized in th...
|
|
WO/2016/141152A1 |
A rebaudioside D containing sweetening composition exhibiting taste like sugar containing a carrier and rebaudioside D is disclosed. A method of making the rebaudioside D containing sweetening composition; and a method of using the rebau...
|
|
WO/2016/134449A1 |
A Stevia rebaudiana plant is characterized by Rebaudioside A (RA) content of 6-20% dry weight and total steviol glycosides content of 15-28% dry weight in the leaf. The plant is developed using selective breeding technologies and identif...
|
|
WO/2016/120403A1 |
The present invention relates to a compound of the general formula (1). wherein the pyranose ring is a-D-galactopyranose, A is selected from The compound of formula (1) is suitable for use in a method for treating a disorder relating to ...
|
|
WO/2016/118932A1 |
The present disclosure relates to branched and linear chimeric compounds containing both nucleic acid and non-nucleic acid moieties, as well as to polynucleotides. The present disclosure also relates to uses thereof for stimulating an im...
|
|
WO/2016/116335A1 |
The present invention describes a process for the selective synthesis of N-Fmoc-doxorubicin-14-O-dicarboxylic acid mono ester derivatives starting from N-Fmoc-doxorubicin using lipase enzymes and bis-acyl donor compounds such as dicarbox...
|
|
WO/2016/115048A1 |
Provided are organic solvent free methods for obtaining compositions comprising one or more rhamnolipids as well as compositions obtainable from said methods.
|
|
WO/2016/110216A1 |
A method for extracting stilbene compounds comprises the following steps: grinding a medicinal material rich in stilbene compounds such as rheum officinale; extracting the medicinal material with a herbal blitzkrieg extractor for one to ...
|
|
WO/2016/109990A1 |
Disclosed is a method for catalytic synthesis of salidroside. The method comprises: enabling total acetyl glucose to react with 4-benzyloxy-phenethyl alcohol under the action of a catalyst to obtain 2-(4-benzyloxyphenyl)ethyl-(2,3,4,6-O-...
|
|
WO/2016/109880A1 |
The invention provides lipid A mimics in which one or both of the sugar residues of a natural lipid A disaccharide backbone has been replaced with an aromatic group. These lipid A mimics may further differ from a natural lipid A molecule...
|
|
WO/2016/112129A1 |
Various embodiments of the present technology provide compositions and methods for a sweetener composition comprising stevia leaf extract, stevia glycosides, and/or Luo Han Guo fruit extract. The sweetener composition provides enhanced t...
|
|
WO/2016/101733A1 |
Provided are a phillygenin glucuronic acid derivative as shown in the formula (I), and a preparation method and antiviral use thereof, etc., wherein R is H, Me, Na+, K+, and so on.
|
|
WO/2016/103530A1 |
Provided are a novel compound having a basic skeleton represented by formula (I) and use of the same as an antioxidant. This compound is derived from 1,5-D-anhydrofructose.
|
|
WO/2016/100689A1 |
Novel steviol glycoside compounds characterized by a first group of four glucopyranose residues attached via the number 13 carbon (C13) of the steviol moiety and a second group of two or three glucopyranose residues attached via the numb...
|
|
WO/2016/098048A1 |
The invention relates to a bactericidal or bacteriostatic composition comprising an acetal or a long-chain alkyl hexitane ether, preferably sorbitan, arlitan or mannitan, the user thereof in the treatment or prevention of infections invo...
|
|
WO/2016/098046A1 |
The invention relates to a bactericidal or bacteriostatic composition comprising a mixture of isomers of monosaccharide alkyl monoacetals or monoethers, the use thereof in the treatment or prevention of infections involving Gram-positive...
|
|
WO/2016/090460A1 |
A Stevia rebaudiana variety characterized by high levels of Rebaudioside C (RC) is disclosed. The variety comprises from about 3-8% by weight RC in the leaf (leaf content) and from about 10-13% total steviol glycosides content (TSG) in t...
|
|
WO/2016/091399A1 |
The present invention relates to synthetic saccharides of general formula (I) that are related to Streptococcus pneumoniae serotype 4 capsular polysaccharide and conjugates thereof. Said conjugate and a pharmaceutical composition contain...
|
|
WO/2016/092030A1 |
A sugar surfactant of formula (I), where R1 is H or an alkyl group comprising 1 to 3 carbon atoms and R2 is a polyhydroxy-hydrocarbyl group comprising a straight hydrocarbyl chain to which at least three hydroxyl groups are directly bond...
|
|
WO/2016/089872A1 |
Compounds, compositions, and methods for treatment and/or prevention of cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of t...
|
|
WO/2016/088076A1 |
The present invention relates to a process for obtaining a mixture of C4-C8 and C9-C18 alkyl monoethers of a saccharide, comprising: a) a first step of acetalization or trans-acetalization of a saccharide or a mixture of saccharides by...
|
|
WO/2016/086108A1 |
Novel diterpene glycosides and methods for purifying the same are provided herein. In addition, compositions comprising the novel diterpene glycosides, as well as methods of using the diterpene glycosides are provided. Novel diterpene gl...
|
|
WO/2016/086097A1 |
A novel diterpene glycoside and methods for preparing and purifying the same are provided herein. In addition, compositions comprising the novel diterpene glycoside, as well as methods of using the diterpene glycoside are provided.
|
|
WO/2016/080850A1 |
Water dispersible, multivalent ligand-lipid constructs that spontaneously and stably incorporate into membranes are disclosed.
|
|
WO/2016/077126A1 |
The present invention relates to certain SGLT-2 inhibitors, such as ertugliflozin or a co-crystal or a pharmaceutically acceptable salt thereof, for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellit...
|
|
WO/2016/070740A1 |
The present invention discloses a class of a compound shown by general formula (I), a pharmaceutically acceptable salt thereof, an easily hydrolyzed prodrug ester or an isomer thereof, a pharmaceutical composition containing this class o...
|
|
WO/2016/070849A1 |
Provided in the present invention are a class of Lincomycin biosynthetic intermediates and a preparation method and use thereof. Specifically provided are Lincomycin biosynthetic intermediates obtained from the genetic modification of a ...
|
|
WO/2016/069826A1 |
Provided are compounds, methods, and pharmaceutical compositions for treating Filoviridae vims infections by administering ribosides, riboside phosphates and prodrugs thereof, of Formula (IV): The compounds, compositions, and methods pro...
|
|
WO/2016/069825A1 |
Provided are methods of preparing compounds and pharmaceutical compositions for treating Filoviridae virus infections the compounds, compositions, and methods provided are particularly useful for the treatment of Marburg virus, Ebola vir...
|
|
WO/2016/069827A1 |
Provided are compounds, methods, and pharmaceutical compositions for treating Filoviridae virus infections by administering ribosides, riboside phosphates and prodrugs thereof, of Formula (I), wherein the position of the nucleoside sugar...
|
|
WO/2016/063262A1 |
The invention relates to a mixture of human milk oligosaccharides that consists essentially of: a)a component A which is 3-FL or DFL, a component B which is LNT, LNnT, LNFP-I or 2'-FL, a component C, which is -LNFP-II when component B is...
|
|
WO/2016/058071A1 |
The present invention relates to the method for extracting and isolating active substances from umbu pulp (Spondias tuberosa Arr. Camara). Besides high acetylcholinesterase inhibitory activity, the active substances also exhibit powerful...
|
|
WO/2016/055601A1 |
This invention generally relates to the field of phosphoramidite derivatives. In particular, the invention relates to N-Acetylgalactosamine phosphoramidite molecules and to conjugates of nucleic acid molecules with N-Acetylgalactosamine ...
|
|
WO/2016/054568A1 |
The present application provides processes for making compounds useful in the making of pesticidal compounds.
|
|
WO/2016/054534A1 |
Disclosed are steviol glycosides referred to as rebaudioside V and rebaudioside W. Also disclosed are methods for producing rebaudioside M (Reb M), rebausoside G (Reb G), rebaudioside KA (Reb KA), rebaudioside V (Reb V) and rebaudioside ...
|
|
WO/2016/054505A1 |
The present application provides processes for making compounds useful in the making of pesticidal compounds.
|
|
WO/2016/054539A1 |
Methyl alpha-L-rhamnopyranosides are selectively alkylated in the 3-position with catalytic amounts of dialkyltin compounds in the presence of halide additives and base.
|
|
WO/2016/054564A1 |
The present application provides processes for making compounds useful in the making of pesticidal compounds.
|
|
WO/2016/054573A1 |
The present application describes processes for making compounds useful in the making of pesticidal compounds.
|
|
WO/2016/054544A1 |
Disclosed are steviol glycosides referred to as rebaudioslde V and rebaudioslde W. Also disclosed are methods for producing rebaudioslde M (Reb M), rebausoside G (Reb G)', rebaudioslde KA (Reb KA), rebaudioslde V (Reb V) and rebaudioslde...
|
|
WO/2016/051187A1 |
There are provided compounds of formula I, wherein R1A to R1E, R2 to R4, R5a, L and X1 to X3 have meanings given in the description, which compounds have antiinflammatory activity (e.g. through inhibition of one or more of members of: th...
|
|
WO/2016/054281A2 |
A method for the purification of idraparinux sodium includes: passing a solution including a crude idraparinux sodium through a column including a sodium ion exchange resin to obtain a first mixture; passing a solution including the firs...
|
